MCID: PSD007
MIFTS: 51

Pseudomyxoma Peritonei malady

Categories: Rare diseases, Cancer diseases

Aliases & Classifications for Pseudomyxoma Peritonei

About this section
Sources:
11Disease Ontology, 46NIH Rare Diseases, 13DISEASES, 52Orphanet, 48Novoseek, 37MeSH, 66UMLS, 43NCIt, 29ICD10 via Orphanet, 38MESH via Orphanet, 67UMLS via Orphanet, 60SNOMED-CT
See all MalaCards sources

Aliases & Descriptions for Pseudomyxoma Peritonei:

Name: Pseudomyxoma Peritonei 11 46 13 52 48 37 66
Pmp 46 52
Syndrome of Pseudomyxoma Peritonei 46
 
Gelatinous Ascites 52
Mucinous Ascites 11
Adenomucinosis 52

Characteristics:

Orphanet epidemiological data:

52
pseudomyxoma peritonei:
Prevalence: 1-9/1000000 (Worldwide); Age of onset: Adult; Age of death: any age

Classifications:



External Ids:

Disease Ontology11 DOID:3559
MeSH37 D011553
NCIt43 C3345
Orphanet52 ORPHA26790
ICD10 via Orphanet29 C78.6
MESH via Orphanet38 D011553
UMLS via Orphanet67 C0033822

Summaries for Pseudomyxoma Peritonei

About this section
NIH Rare Diseases:46 Pseudomyxoma peritonei (pmp) is a rare condition characterized by the presence of mucin in the abdominal (peritoneal) cavity. while the most common cause of pmp is appendix cancer, several types of tumors (including non-cancerous tumors) can cause pmp. signs and symptoms may include an increase in abdominal size or bloating; inguinal hernia (in men); an ovarian mass, felt during a routine pelvic exam (in women); pain or discomfort in the abdomen; and/or appendicitis. treatment depends on the underlying cause of the condition (the location and type of the original tumor, including whether it is malignant) and the extent of spreading. it may involve surgically removing as much of the tumor as possible (debulking); radiotherapy; and/or chemotherapy. last updated: 4/11/2016

MalaCards based summary: Pseudomyxoma Peritonei, also known as pmp, is related to ovarian cystadenocarcinoma and colorectal cancer, and has symptoms including ascites, abnormality of the peritoneum and abnormality of the abdominal wall. An important gene associated with Pseudomyxoma Peritonei is MUC2 (Mucin 2, Oligomeric Mucus/Gel-Forming), and among its related pathways are Thyroid cancer and Bladder cancer. Affiliated tissues include appendix, colon and small intestine, and related mouse phenotype embryo.

Disease Ontology:11 An appendix cancer that is characterized by progressive accumulation of mucus-secreting tumor cells within the abdomen and pelvis.

Wikipedia:69 Pseudomyxoma peritonei (PMP) is a clinical condition caused by cancerous cells (mucinous adenocarcinoma)... more...

Related Diseases for Pseudomyxoma Peritonei

About this section

Diseases related to Pseudomyxoma Peritonei via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 178)
idRelated DiseaseScoreTop Affiliating Genes
1ovarian cystadenocarcinoma30.3MUC1, MUC2
2colorectal cancer26.7CDH1, CDX2, KRAS, KRT20, MCL1, MUC1
3mucinous adenocarcinoma11.6
4gelatinous ascites11.6
5peritonitis10.7
6adenocarcinoma10.7
7carbuncle10.6KRT20, MUC2
8glottis squamous cell carcinoma10.6CDX2, MUC2
9pseudounicornuate uterus10.6KRAS, KRT20
10sensory system cancer10.5CDX2, KRT20
11pulmonary neuroendocrine tumor10.5CDX2, KRT20
12cellular phase chronic idiopathic myelofibrosis10.5CDX2, KRT20
13ovarian melanoma10.5CDX2, KRT20
14cystadenocarcinoma10.5
15cervix squamous papilloma10.5CDX2, MUC2
16klatskin's tumor10.5CDX2, KRT20
17giant cell myocarditis10.5CDH1, KRT20
18congenital heart disease10.5CDX2, KRT20
19acute sanguinous otitis media10.5CDX2, KRAS
20chronic eustachian salpingitis10.5CDX2, KRT20
21steatitis10.5CDH1, KRT20
22papilloma10.5KRAS, KRT20
23adenoid basal cell carcinoma10.5CDH1, KRT20
24mucinous cystadenocarcinoma10.5
25ureter adenocarcinoma10.5CDX2, KRAS
26hypoparathyroidism-intellectual disability-dysmorphism syndrome10.4CDX2, KRT20
27gastric cancer risk after h. pylori infection10.4CDH1, KRAS
28teratoma10.4
29pyoderma10.4KRAS, KRT20
30food allergy10.4CDX2, KRT20
31cystic teratoma10.4
32vulva basal cell carcinoma10.4CDH1, KRT20
33cystadenoma10.3
34mucinous adenocarcinoma of the appendix10.3
35lacrimal gland mucoepidermoid carcinoma10.3MUC1, MUC2
36ovarian cancer, somatic10.3CDH1, KRAS
37novak syndrome10.3CDX2, MUC2
38persian gulf syndrome10.3CDH1, KRT20
39inguinal hernia10.3
40appendiceal neoplasm10.3
41pemphigus vulgaris, familial10.3KRT20, MUC1
42acute cholangitis10.3CDX2, MUC2
43appendix adenocarcinoma10.3CDX2, KRT20, MUC2
44bartholin's gland small cell carcinoma10.3CDX2, KRT20, MUC2
45endometriosis10.3
46bladder calculus10.3CDX2, KRT20, MUC2
47cervix endometriosis10.3CDX2, KRT20, MUC2
48gastric cancer, somatic10.3CDH1, KRAS
49encephalopahty, lethal, due to defective mitochondrial peroxisomal fission10.2MUC1, MUC2
50intrahepatic cholangiocarcinoma10.2CDX2, KRAS, MUC2

Graphical network of the top 20 diseases related to Pseudomyxoma Peritonei:



Diseases related to pseudomyxoma peritonei

Symptoms for Pseudomyxoma Peritonei

About this section

Symptoms:

 52 (show all 12)
  • ascites
  • weight loss
  • nausea and vomiting
  • constipation
  • abdominal pain
  • inflammation of the large intestine
  • respiratory insufficiency
  • abnormality of the peritoneum
  • lymphadenopathy
  • abnormality of the abdominal wall
  • intestinal obstruction
  • hernia

HPO human phenotypes related to Pseudomyxoma Peritonei:

(show all 17)
id Description Frequency HPO Source Accession
1 ascites hallmark (90%) HP:0001541
2 abnormality of the peritoneum hallmark (90%) HP:0002585
3 abnormality of the abdominal wall hallmark (90%) HP:0004298
4 inflammation of the large intestine typical (50%) HP:0002037
5 weight loss occasional (7.5%) HP:0001824
6 nausea and vomiting occasional (7.5%) HP:0002017
7 constipation occasional (7.5%) HP:0002019
8 abdominal pain occasional (7.5%) HP:0002027
9 respiratory insufficiency occasional (7.5%) HP:0002093
10 lymphadenopathy occasional (7.5%) HP:0002716
11 neoplasm of the pancreas occasional (7.5%) HP:0002894
12 intestinal obstruction occasional (7.5%) HP:0005214
13 neoplasm of the stomach occasional (7.5%) HP:0006753
14 abnormal renal physiology occasional (7.5%) HP:0012211
15 neoplasm of the colon occasional (7.5%) HP:0100273
16 ovarian neoplasm occasional (7.5%) HP:0100615
17 hernia occasional (7.5%) HP:0100790

UMLS symptoms related to Pseudomyxoma Peritonei:


cachexia, cancer pain, tumor pain, metastatic pain, breakthrough pain, hepatic hydrothorax

Drugs & Therapeutics for Pseudomyxoma Peritonei

About this section

Drugs for Pseudomyxoma Peritonei (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 16)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
OxaliplatinPhase 2, Phase 1136661825-94-35310940, 9887054, 43805, 6857599, 9887054
Synonyms:
CHEMBL1201055
CID9887054
D01790
DACPLAT
Diaminocyclohexane Oxalatoplatinum
Eloxatin
Eloxatin (TN)
Elplat
Foloxatine
L-OHP
Oxalatoplatin
 
Oxalatoplatinum
Oxaliplatin (JAN/USAN/INN)
Oxaliplatin [Usan:Inn:Ban]
Oxaliplatino [Spanish]
Oxaliplatinum [Latin]
Oxaloplatine [French]
Oxaloplatino [Spanish]
Transplatin
oxaliplatin
oxaliplatine
oxaliplatino
oxaliplatinum
2
leucovorinPhase 2, Phase 1104758-05-9143, 54575
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
3
DexlansoprazolePhase 2204138530-94-6, 103577-45-39578005
Synonyms:
138530-94-6
CHEMBL1201863
CID9578005
D08903
Dexlansoprazole (INN/USAN)
KS-1075
 
Kapidex
MolPort-002-885-834
T 168390
TAK 390
UNII-UYE4T5I70X
ZINC00599734
dexlansoprazole
4
AmoxicillinPhase 241826787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
5
ClarithromycinPhase 225881103-11-984029
Synonyms:
(14R)-14-Hydroxyclarithromycin
116836-41-0
6-O-Methylerythromycin
6-O-Methylerythromycin a
6-O-methyl erythromycin
81103-11-9
A-56268
AC-6813
AC1L1HJO
AC1L36NJ
AC1NFSZE
AC1NR4MY
AC1NSJWH
AC1O52DV
AC1Q6O1T
ANX-015
Abbotic
Abbott-56268
Adel
Astromen
BB_NC-1450
BIDD:GT0200
BSPBio_003453
Biaxin
Biaxin (TN)
Biaxin HP
Biaxin XL
Biaxin filmtab
Biaxin xl filmtab
Bicrolid
Bio-0020
C06912
C2220
C30H54O11.C9H19NO2
CCRIS 8833
CHEBI:136451
CHEBI:3732
CHEMBL143
CHEMBL1741
CID10147055
CID10328822
CID11814635
CID11828745
CID11969952
CID4663848
CID489010
CID5284534
CID5311050
CID54688
CID6426662
CID84029
CID9810688
CID9811194
CLA
CLARITHROMYCIN
CLM & IL-12
CPD000466382
CRL-1605 & Clarithromycin
CTY
Clacine
Clambiotic
Claribid
Claricide
Clarith
Clarithromycin & Interleukin-12
Clarithromycin (JP15/USP/INN)
Clarithromycin [USAN:INN:BAN:JAN]
Clarithromycin extended release
Clarithromycin suspension or tablets
Clarithromycina
Clarithromycine
Clarithromycine [INN-French]
 
Clarithromycinum
Clarithromycinum [INN-Latin]
Claritromicina
Claritromicina [INN-Spanish]
Clathromycin
Cyllid
Cyllind
D00276
DRG-0099
DivK1c_006655
HMS1922H09
HMS2051G18
HMS2090O11
HMS2094M05
Helas
Heliclar
I05-0074
KBio1_001599
KBio2_000509
KBio2_003077
KBio2_005645
KBio3_002673
KBioGR_001218
KBioSS_000509
Klacid
Klaciped
Klaricid
Klaricid H.P
Klaricid H.P.
Klaricid Pediatric
Klaricid XL
Klarid
Klarin
Klax
Kofron
LMPK04000014
LS-1812
Lactoferrin B & Clarithromycin
Lactoferrin H & Clarithromycin
MLS000759516
MLS001201751
MLS001424066
Mabicrol
Macladin
Maclar
Mavid
MolPort-002-507-425
MolPort-003-845-969
MolPort-005-910-192
MolPort-005-934-146
NCGC00178054-01
NSC643733
Naxy
O(6)-methylerythromycin
SAM001246748
SDP-015
SMR000466382
SPBio_001855
SPECTRUM1504231
STK801952
SpecPlus_000559
Spectrum2_001668
Spectrum3_001667
Spectrum4_000629
Spectrum5_001729
Spectrum_000089
TE-031
TE031
UNII-H1250JIK0A
Veclam
Zeclar
clarithromycin
clarithromycina
hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexame
6
Proton pump inhibitorsPhase 21057
Synonyms:
 
PPIs
7
LansoprazolePhase 2204103577-45-33883
Synonyms:
103577-45-3
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
A 65006
A-65006
AB00052388
ABT-006
AC1L1GX8
AG 1749
AG-1749
Abbot Brand of Lansoprazole
Agopton
Almirall Brand of Lansoprazole
Amarin
Aprazol
BIDD:GT0006
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
Bamalite
Bio-0824
Biuret
Biuret Gr
Biuret Reagent
Biuret Reagent Solution
Blason
C058687
C16H14F3N3O2S
CAS-103577-45-3
CG-4801
CHEBI:6375
CHEMBL480
CID3883
CPD000058469
Compraz
D00355
DB00448
Dakar
DivK1c_000920
EU-0100709
FT-0082011
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS502N22
HSDB 7204
Hoechst Brand of Lansoprazole
Hormona Brand of Lansoprazole
I06-0018
IDI1_000920
Ilsatec
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
L 8533
L8533_SIGMA
LS-33080
Lancid
Lanfast
Lanproton
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
Lansoprazole
Lansoprazole (JAN/USP/INN)
Lansoprazole [USAN:BAN:INN]
Lansoprazole [Usan:Ban:Inn]
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
Lanston
 
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle Brand of Lansoprazole
Limpidex
Linamarin
Lopac-L-8533
Lopac0_000709
MLS-0003247.0001
MLS000069705
MLS000759405
MLS001074170
Mesactol
MolPort-003-666-508
MolPort-006-394-760
Monolitum
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-06
NCGC00015615-11
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NINDS_000920
Ogast
Ogastro
Opiren
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
PrevOnco
Prevacid
Prevacid (TN)
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid SoluTab
Prevacid Solutab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
Prevpac
Prezal
Pro Ulco
Promeco
Promeco Brand of Lansoprazole
Promp
Prosogan
S1354_Selleck
SAM001246544
SMR000058469
SPBio_000488
SPBio_002992
SPECTRUM1503926
STK621169
Salvar Brand of Lansoprazole
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
Spectrum_001580
Suprecid
TAK 390MR
TAK-390MR
TAK390MR
TAP Brand of Lansoprazole
TL8000155
Takeda Brand of Lansoprazole
Takepron
Tecnobio Brand of Lansoprazole
UNII-0K5C5T2QPG
Ulpax
Vinas Brand of Lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton
lansoprazole
lansoprazole sulphone
lanzoprazole
8Alkylating AgentsPhase 24573
9
FluorouracilPhase 2172851-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
10
LevoleucovorinPhase 169668538-85-2
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-5-formyltetrahydrofolic acid
(6S)-Folinic acid
(6S)-Leucovorin
 
(S)-Leucovorin
Citrovorum factor
L-Folinic acid
Levofolene
Levofolinic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
11pancreatic polypeptidePhase 120
12
FloxuridinePhase 14850-91-95790
Synonyms:
1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil
1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil
1beta-D-2'-Deoxyribofuranosyl-5-flurouracil
2'-Deoxy-5-fluorouridine
5 Fluorodeoxyuridine
5-FUDR
5-Fluoro-2-desoxyuridine
5-Fluorodeoxyuridine
5-Fluorouracil 2'-deoxyriboside
5-Fluorouracil deoxyriboside
5FDU
Deoxyfluorouridine
 
FDUR
FDURD
FUDR
FdU
Floxiridina
Floxiridina [INN-Spanish]
Floxuridin
Floxuridine
Floxuridinum
Floxuridinum [INN-Latin]
Fluorodeoxyuridine
Fluoruridine Deoxyribose
WR-138720
beta-5-Fluoro-2'-deoxyuridine
13
GemcitabinePhase 1192895058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
14
CarboplatinPhase 1194241575-94-410339178, 498142, 38904
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
15COLANutraceuticalPhase 11824
16
nivolumab254946414-94-4
Synonyms:
BMS-936558
 
MDX-1106
ONO-4538
nivolumab

Interventional clinical trials:

(show all 14)
idNameStatusNCT IDPhase
1Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal OriginRecruitingNCT02387203Phase 2
2Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-CEnrolling by invitationNCT02040142Phase 2
3A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal CarcinomatosisTerminatedNCT00352755Phase 2
4Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerCompletedNCT01652794Phase 1
5Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumCompletedNCT00005860Phase 1
6Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerCompletedNCT01764789
7Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)CompletedNCT01126346
8Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was PerformedRecruitingNCT01617382
9Gastrointestinal Microbiome Study of Appendiceal CancerRecruitingNCT02599116
10Peritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesRecruitingNCT02073500
11Results of CRS and Debulking in PMP PatientsActive, not recruitingNCT01427101
12French National Registry of Rare Peritoneal Surface MalignanciesActive, not recruitingNCT02834169
13Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC PatientsEnrolling by invitationNCT02374411
14Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNot yet recruitingNCT02834013

Search NIH Clinical Center for Pseudomyxoma Peritonei


Cochrane evidence based reviews: pseudomyxoma peritonei

Genetic Tests for Pseudomyxoma Peritonei

About this section

Anatomical Context for Pseudomyxoma Peritonei

About this section

MalaCards organs/tissues related to Pseudomyxoma Peritonei:

34
Appendix, Colon, Small intestine, Pancreas, Ovary, Breast, Testes

Animal Models for Pseudomyxoma Peritonei or affiliated genes

About this section

MGI Mouse Phenotypes related to Pseudomyxoma Peritonei:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053807.8CDH1, CDH2, CDX2, KRAS, MCL1

Publications for Pseudomyxoma Peritonei

About this section

Articles related to Pseudomyxoma Peritonei:

(show top 50)    (show all 559)
idTitleAuthorsYear
1
Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei. (27038681)
2016
2
Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei. (27602245)
2016
3
Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines. (25929336)
2015
4
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in a woman with pseudomyxoma peritonei: A case report. (26076000)
2014
5
Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. (25329419)
2014
6
Orthotopic animal model of pseudomyxoma peritonei: An in vivo model to test anti-angiogenic drug effects. (24814606)
2014
7
Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis. (23199549)
2013
8
Role of preoperative sonography in the diagnosis and pathologic staging of pseudomyxoma peritonei. (23980216)
2013
9
Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei. (23720095)
2013
10
A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei. (23844722)
2013
11
Pseudomyxoma Peritonei: Inflammatory Responses in the Peritoneal Microenvironment. (24046117)
2013
12
Pseudomyxoma peritonei (mucinous carcinoma peritonei) preceded by intraductal papillary neoplasm of the bile duct. (22406366)
2012
13
Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin secreted in pseudomyxoma peritonei. (22261589)
2012
14
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. (22614976)
2012
15
Extraperitoneal presentation of pseudomyxoma peritonei as retroperitoneal invasion with skin fistula-a case report. (22202264)
2011
16
Commentary on 'Survival of patients with pseudomyxoma peritonei treated by serial debulking'. (20718839)
2010
17
Presumed fungal retinitis associated with pseudomyxoma peritonei. (21686849)
2009
18
Chemo-hyperthermic peritoneal perfusion (CHPP) for appendiceal pseudomyxoma peritonei. (19390942)
2009
19
Paraneoplastic cerebellar degeneration in a patient with pseudomyxoma peritonei and breast cancer: case report and literature review. (19779120)
2009
20
Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei. (19180588)
2009
21
Adenocarcinoma of urachal cyst associated with pseudomyxoma peritonei masquerading as abdominal tuberculosis: A case report and review of literature. (19468408)
2008
22
Low-grade mucinous epithelial neoplasm (intestinal type) arising in a mature sacrococcygeal teratoma with late recurrence as pseudomyxoma peritonei. (18289636)
2008
23
Incidental finding of pseudomyxoma peritonei in a deceased organ donor: implications on organ donation. (17239029)
2007
24
Pseudomyxoma peritonei: A rose by any other name... (17063093)
2006
25
Ten years experience in the treatment of pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion. (17203755)
2006
26
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms. (16838392)
2006
27
Pseudomyxoma peritonei confined to the retroperitoneum occurring 35 years after appendicectomy. (15083325)
2004
28
The etiology, clinical presentation, and management of pseudomyxoma peritonei. (14567019)
2003
29
The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei. (12099657)
2002
30
Pseudomyxoma peritonei of appendiceal cancer with metastasis to the stomach: report of a case. (12107784)
2002
31
Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei (Br J Surg 2001; 88: 458-63). (11488802)
2001
32
A rare case of pseudomyxoma peritonei presenting an unusual inguinal hernia and splenic metastasis. (11446896)
2001
33
Use of ultrasonic surgical aspirator in operative cytoreduction of pseudomyxoma peritonei. (10789759)
2000
34
Congenital pleuroperitoneal communication in a patient with pseudomyxoma peritonei. (10738273)
2000
35
Pseudomyxoma peritonei. (9660531)
1998
36
Cytogenetic changes in ovarian mucinous cystadenocarcinoma of low malignant potential with persistent pseudomyxoma peritonei. (7889512)
1995
37
Pseudomyxoma peritonei: a report of eight cases. (7829144)
1994
38
Pseudomyxoma peritonei from metastatic colloid carcinoma of the breast. (1846836)
1991
39
Magnetic resonance imaging of pseudomyxoma peritonei. (2663488)
1989
40
CT of pseudomyxoma peritonei. (3499780)
1987
41
Pseudomyxoma peritonei--benign or malignant. (3758624)
1986
42
Successful treatment of pseudomyxoma peritonei of ovarian origin with cis-platinum, doxorubicin, and cyclophosphamide. (4054721)
1985
43
Calcification of pseudomyxoma peritonei following intraperitoneal chemotherapy: CT demonstration. (2997312)
1985
44
Pseudomyxoma peritonei associated with mucinous adenocarcinoma of the pancreas: CT findings and CT-guided biopsy. (6323557)
1984
45
Pseudomyxoma peritonei et ovarii with an occult neoplasm of appendix: case report. (683699)
1978
46
Pseudomyxoma peritonei. (4645609)
1972
47
Pseudomyxoma peritonei. (4185408)
1969
48
The mucous substance in pseudomyxoma peritonei II. Isolation and properties of a sialomucopolysaccharide. (4226216)
1966
49
"MUCOCELE APPENDICIS" WITH PSEUDOMYXOMA PERITONEI AND PULMONARY METASTASES. (14154710)
1964
50
Mucinous adenocarcinoma of the cecum with gross findings simulating pseudomyxoma peritonei: report of a case. (13373298)
1956

Variations for Pseudomyxoma Peritonei

About this section

Cosmic variations for Pseudomyxoma Peritonei:

8 (show all 39)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA Conf
1COSM516KRASperitoneum,appendix,other,pseudomyxoma peritoneic.34G>Tp.G12C0
2COSM27895GNASperitoneum,appendix,other,pseudomyxoma peritoneic.602G>Ap.R201H0
3COSM521KRASperitoneum,appendix,other,pseudomyxoma peritoneic.35G>Ap.G12D0
4COSM27887GNASperitoneum,appendix,other,pseudomyxoma peritoneic.601C>Tp.R201C0
5COSM4169159GNASperitoneum,appendix,other,pseudomyxoma peritoneic.596G>Ap.R199H0
6COSM532KRASperitoneum,appendix,other,pseudomyxoma peritoneic.38G>Ap.G13D0
7COSM520KRASperitoneum,appendix,other,pseudomyxoma peritoneic.35G>Tp.G12V0
8COSM4169155GNASperitoneum,appendix,other,pseudomyxoma peritoneic.706C>Tp.Q236*0
9COSM4169153KRASperitoneum,appendix,other,pseudomyxoma peritoneic.389C>Tp.A130V0
10COSM4386691ATMperitoneum,appendix,other,pseudomyxoma peritoneic.3980T>Gp.L1327*0
11COSM763PIK3CAperitoneum,appendix,other,pseudomyxoma peritoneic.1633G>Ap.E545K0
12COSM546KRASperitoneum,colon,other,pseudomyxoma peritoneic.175G>Ap.A59T0
13COSM4169137KRASperitoneum,appendix,other,pseudomyxoma peritoneic.418C>Tp.P140S0
14COSM539KRASperitoneum,appendix,other,pseudomyxoma peritoneic.44G>Ap.G15D0
15COSM4169157SMAD2peritoneum,appendix,other,pseudomyxoma peritoneic.1391C>Tp.S464L0
16COSM517KRASperitoneum,appendix,other,pseudomyxoma peritoneic.34G>Ap.G12S0
17COSM1360888KRASperitoneum,appendix,other,pseudomyxoma peritoneic.28G>Ap.G10R0
18COSM529KRASperitoneum,appendix,other,pseudomyxoma peritoneic.37G>Cp.G13R0
19COSM1685346GNASperitoneum,appendix,other,pseudomyxoma peritoneic.677G>Ap.G226D0
20COSM10777TP53peritoneum,appendix,other,pseudomyxoma peritoneic.715A>Gp.N239D0
21COSM1169214KRASperitoneum,appendix,other,pseudomyxoma peritoneic.101C>Tp.P34L0
22COSM4169135SMAD2peritoneum,appendix,other,pseudomyxoma peritoneic.1388G>Ap.C463Y0
23COSM522KRASperitoneum,appendix,other,pseudomyxoma peritoneic.35G>Cp.G12A0
24COSM51382KRASperitoneum,appendix,other,pseudomyxoma peritoneic.50G>Ap.S17N0
25COSM33765AKT1peritoneum,appendix,other,pseudomyxoma peritoneic.49G>Ap.E17K0
26COSM4169145GNASperitoneum,appendix,other,pseudomyxoma peritoneic.643G>Ap.D215N0
27COSM1562184KRASperitoneum,appendix,other,pseudomyxoma peritoneic.25G>Ap.V9I0
28COSM1150895SMAD4peritoneum,appendix,other,pseudomyxoma peritoneic.1157G>Ap.G386D0
29COSM3727814KRASperitoneum,appendix,other,pseudomyxoma peritoneic.91G>Ap.E31K0
30COSM99221GNASperitoneum,appendix,other,pseudomyxoma peritoneic.602G>Tp.R201L0
31COSM12722KRASperitoneum,appendix,other,pseudomyxoma peritoneic.40G>Ap.V14I0
32COSM4169134SMAD2peritoneum,appendix,other,pseudomyxoma peritoneic.1400C>Tp.S467L0
33COSM4169147KRASperitoneum,appendix,other,pseudomyxoma peritoneic.412G>Ap.G138R0
34COSM14122SMAD4peritoneum,appendix,other,pseudomyxoma peritoneic.1082G>Ap.R361H0
35COSM527KRASperitoneum,appendix,other,pseudomyxoma peritoneic.37G>Tp.G13C0
36COSM302311GNASperitoneum,appendix,other,pseudomyxoma peritoneic.692G>Ap.R231H0
37COSM4169149KRASperitoneum,appendix,other,pseudomyxoma peritoneic.380C>Tp.T127I0
38COSM4169161KRASperitoneum,appendix,other,pseudomyxoma peritoneic.59C>Tp.T20M0
39COSM110699KRASperitoneum,appendix,other,pseudomyxoma peritoneic.29G>Ap.G10E0

Expression for genes affiliated with Pseudomyxoma Peritonei

About this section
Search GEO for disease gene expression data for Pseudomyxoma Peritonei.

Pathways for genes affiliated with Pseudomyxoma Peritonei

About this section

GO Terms for genes affiliated with Pseudomyxoma Peritonei

About this section

Cellular components related to Pseudomyxoma Peritonei according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1catenin complexGO:00163429.3CDH1, CDH2
2cortical actin cytoskeletonGO:00308649.0CDH1, CDH2
3Golgi lumenGO:00057968.9MUC1, MUC2, MUC6

Biological processes related to Pseudomyxoma Peritonei according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1maintenance of gastrointestinal epitheliumGO:003027710.1MUC2, MUC6
2striated muscle cell differentiationGO:00511469.6CDH2, KRAS
3O-glycan processingGO:00162669.3MUC1, MUC2, MUC6
4establishment of protein localization to plasma membraneGO:00900029.1CDH1, CDH2
5adherens junction organizationGO:00343329.0CDH1, CDH2

Molecular functions related to Pseudomyxoma Peritonei according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1gamma-catenin bindingGO:00452959.0CDH1, CDH2

Sources for Pseudomyxoma Peritonei

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet